GSK grabs FDA OK for new shingles vaccine, which will now tackle a key Merck franchise
Watch out Merck. GlaxoSmithKline is coming for a chunk of your shingles vaccine franchise.
Late on Friday the FDA announced that it had green-lighted Shingrix …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.